BEST UNLIMITED TURBO LONG CERTIFICATE - ELI LILLY & CO | Market Closed - Euronext Paris 12:30:01 2024-06-07 pm EDT | ||
| 6.1 EUR | +5.54% |
|
| Current month | +11.25% | ||
| 1 month | +27.62% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
ELI LILLY AND COMPANY
Latest news about ELI LILLY AND COMPANY
More news
| Date | Price | Change |
|---|---|---|
| 24-06-07 | 6.03 | +4.33% |
| 24-06-06 | 5.78 | +0.70% |
| 24-06-05 | 5.74 | +2.32% |
| 24-06-04 | 5.61 | -1.58% |
| 24-06-03 | 5.7 | +5.17% |
Real-time Euronext Paris
Last update June 07, 2024 at 12:30 pm EDT
More quotesStatic data
| Product type | Knock-Out without Stop Loss |
|---|---|
| Buy / Sell | CALL |
| Underlying | ELI LILLY AND COMPANY |
| Issuer | 
Société Générale
|
| W983S | |
| ISIN | DE000SU5Z0V6 |
| Date issued | 2023-12-19 |
| Strike | 526.1 $ |
| Maturity | Unlimited |
| Parity | 50 : 1 |
| Emission price | 1.33 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 6.13 € |
|---|---|
| Lowest since issue | 1.23 € |
| Spread | 0.02 € |
| Spread % | 0.33% |
Company Profile
Eli Lilly and Company is one of the world's leading pharmaceutical groups. Net sales break down by therapeutic field as follows:
- endocrinology (57.7%): products for treating osteoporosis, diabetes, and growth problems;
- oncology (19.5%);
- immunology diseases (11.1%);
- neurology (8.4%): primarily drugs used in treating depression and schizophrenia;
- other (3.3%).
Net sales are distributed geographically as follows: the United States (63.9%), Europe (18.1%), Japan (4.9%), China (4.5%) and other (8.6%).
Sector
-
Consensus: Eli Lilly and Company
Sell
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
850
USD
Average target price
853.8
USD
Spread / Average Target
+0.44%
- Stock Market
- Certificates
- W983S Certificat
